ALLOVIR, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7509 USD | -3.73% |
|
+0.20% | +9.56% |
| 06-11 | AlloVir, Inc. Enter into Termination of Sublease Agreement with AMAG Pharmaceuticals, Inc | CI |
| 05-13 | AlloVir, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Bearish |
| Resistance | 0.7958 | 0.8164 | 1.550 |
| Spread/Res. | -6.41% | -8.77% | -51.95% |
| Spread/Supp. | +2.38% | +16.48% | +14.30% |
| Support | 0.7275 | 0.6394 | 0.6516 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- ALVR Stock
- Charts AlloVir, Inc.
